Dubroff: Growth stock investors wake up to the bottom line
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →First quarter expenses more than doubled at Sienna Biopharmaceuticals
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →PacWest Bancorp reports increase in net earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →PennyMac Financial earnings go up
Westlake Village-based PennyMac Financial Services reported an increase in earnings for the fourth quarter of 2017 and for the entire year, compared to 2016, on Feb. 8. The company reported a net income of $123.9 million for the fourth quarter of 2017. Net income attributable to common stockholders was $62.3 million, or $2.44 per diluted Read More →
Read More →Citizens Business Bank hits all-time highs for earnings
CVB Financial Corp., parent company for Citizens Business Bank, reported all-time highs in fourth quarter and year end earnings for 2017 on Jan. 24. The company’s net earnings for the fourth quarter were $17.9 million, or 16 cents per share, compared to $29.7 million for the third quarter. Its full year net earnings for 2017 Read More →
Read More →Inogen reports record revenues for third quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen product sales slip but income stays steady
Net income at biotech giant Amgen stayed flat for the third quarter, despite a slight downtick in revenues to $5.8 billion, the company reported Oct. 25. Product sales saw a slight decline, including Neupogen, Epogen and its blockbuster rheumatoid arthritis drug Enbrel, which fell 6 percent, but net income stayed steady at a little more Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
